ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Theraclion

Theraclion (ALTHE)

0.362
0.002
(0.56%)
Closed April 24 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.362
Bid
0.362
Ask
0.363
Volume
13
0.361 Day's Range 0.362
0.30 52 Week Range 0.848
Market Cap
Previous Close
0.36
Open
0.361
Last Trade
10
@
0.362
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
19,208
Shares Outstanding
45,732,250
Dividend Yield
-
PE Ratio
-3.32
Earnings Per Share (EPS)
-0.11
Revenue
1.37M
Net Profit
-4.96M

About Theraclion

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Headquarters
Malakoff, Hauts-de-seine, Fra
Founded
1970
Theraclion is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALTHE. The last closing price for Theraclion was 0.36 €. Over the last year, Theraclion shares have traded in a share price range of 0.30 € to 0.848 €.

Theraclion currently has 45,732,250 shares outstanding. The market capitalization of Theraclion is 16.46 € million. Theraclion has a price to earnings ratio (PE ratio) of -3.32.

ALTHE Latest News

THERACLION ANNONCE SES RÉSULTATS FINANCIERS 2023 ET POURSUIT SA FEUILLE DE ROUTE

Poursuite de la stratégie centrée sur les accès aux marchés américain et chinois pour le SONOVEIN®, et à son amélioration grâce à la R&D ; Démarrage rapide de l’étude pivot aux Etats-Unis :...

THERACLION POURSUIT SA STRATÉGIE ET ANNONCE SON CHIFFRE D’AFFAIRES 2023

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), société innovante développant une plateforme robotique pour le traitement non invasif par ultrasons focalisés (HIFU...

THERACLION ATTEINT SES OBJECTIFS STRATÉGIQUES 2023

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, dresse aujourd’hui le bilan de ses...

THERACLION FRANCHIT UNE ÉTAPE IMPORTANTE EN VUE DE L’ACCÈS AU MARCHÉ AMÉRICAIN : PREMIERS PATIENTS TRAITÉS AVEC SONOVEIN® DANS L’ÉTUDE PIVOT APPROUVÉE PAR LA FDA

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, annonce aujourd'hui que les...

THERACLION ANNONCE SES RÉSULTATS FINANCIERS SEMESTRIELS 2023 ET FAIT LE POINT SUR L’EXÉCUTION DE SA STRATÉGIE

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, présente ses résultats...

THERACLION ÉXECUTE SA STRATÉGIE AU PREMIER SEMESTRE

Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, présente son bilan du premier semestre...

ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DE THERACLION DU 30 JUIN 2023

TOUTES LES RÉSOLUTIONS AGRÉÉES PAR LE CONSEIL D’ADMINISTRATION ONT ÉTÉ ADOPTÉES PAR LES ACTIONNAIRES Regulatory News: Page sur THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante...

 THERACLION ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL

Conclusion d’un partenariat majeur avec un actionnaire historique Furui. Obtention de moyens financiers renforcés qui devraient assurer la visibilité financière de l’entreprise à 2 ans...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.013-3.466666666670.3750.380.341280680.36275506DE
4-0.017-4.485488126650.3790.3890.339124560.36436629DE
12-0.178-32.9629629630.540.540.308192080.39834513DE
26-0.148-29.01960784310.510.680.3277270.4145519DE
52-0.37-50.54644808740.7320.8480.3191350.46996726DE
156-1.508-80.64171122991.872.280.3185190.98429669DE
260-1.588-81.43589743591.952.760.3207051.22955038DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ILAGIntelligent Living Application Group Inc
$ 0.725
(34.26%)
1.69M
THMOThermoGenesis Holdings Inc
$ 0.83
(27.69%)
1.25k
NUWENewellis Inc
$ 0.3199
(26.89%)
1.43M
CDTXCidara Therapeutics Inc
$ 15.21
(23.76%)
159.58k
AIREreAlpha Tech Corporation
$ 1.42
(22.41%)
2.28M
FBLGraniteShares ETF Trust GraniteShares
$ 20.72
(-22.60%)
655.51k
METAMeta Platforms Inc
$ 439.00
(-11.04%)
6.66M
INMInMed Pharmaceuticals Inc
$ 0.27
(-10.89%)
581.44k
AKLIAkili Inc
$ 0.221
(-10.89%)
5k
JAKKJAKKS Pacific Inc
$ 21.05
(-10.27%)
4.59k
SQQQProShares UltraPro Short QQQ
$ 12.1398
(2.79%)
9.04M
METAMeta Platforms Inc
$ 439.00
(-11.04%)
6.66M
HCPHashiCorp Inc
$ 32.85
(4.58%)
4.37M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.425
(-0.07%)
3.69M
QQQInvesco QQQ Trust Series 1
$ 422.55
(-0.93%)
3.4M

Discussion

View Full Feed
djohn djohn 4 minutes ago
I have met Stephanie several times an actually she is a very nice person. I talk to her for a long time at the last "in person" ASM when I was the only shareholder who attended. So she remembers me. Since then she has always responded to my emails. You just can't over do it or ask her questions that
ASM
threewheeler threewheeler 4 minutes ago
LBWR Security Details
Share Structure
Market Cap Market Cap
394,238
04/23/2024
Authorized Shares
1,000,000,000
04/23/2024
Outstanding Shares
179,199,001
04/23/2024
Restricted
147,449,003
04/23/2024
Unre
DTC
NoMoDo NoMoDo 5 minutes ago
You are correct, they won't sell. There are convertible loans however that will likely be converted. The loans are at a fixed price - which is good. The first one is $50k worth at 1.2 cents. That comes out to about 4mil shares. That means that we will likely see around 1.2 cents/share for a few
FORW
BADALI BADALI 5 minutes ago
https://x.com/moneytingzz123/status/1783178648100745330?s=46&t=y7yrqIlNM3fsfWkjz_Q1IQ
IGPK
BADALI BADALI 5 minutes ago
https://x.com/moneytingzz123/status/1783178648100745330?s=46&t=y7yrqIlNM3fsfWkjz_Q1IQ
IGPK
shoondale shoondale 5 minutes ago
This is dirty. I think you are right steal. Legitimate Businessmen don't act this way.
MGON
palaypu0406 palaypu0406 5 minutes ago
my relationship with RD is like two thick souls with common interests to serve the company and its shareholders...
and because of this we may appear to be breaking bricks but we have tons of affinity ...
ITUP
BigBadWolf BigBadWolf 5 minutes ago
https://www.foxwilliams.com/2022/03/01/director-responsibility-10-ways-a-director-could-be-held-personally-liable-in-2022/
A recently published case has shone a new light on the well-known fact of English company law – that a company has its own legal personality and is therefore separate a
TSOI
JMCK6193 JMCK6193 6 minutes ago
And yet she's falling like a rock today and still falling in the after-hours. Shorts are making a killing now.
And it pisses me off.
AGBA
Rainer Rainer 6 minutes ago
some decent runners in otc this week, some on huge volume.
Vexari Vexari 6 minutes ago
People will wake when it hits home

Bootstraps are an important tool

Psychologically speaking
PFE
Truthsocial Truthsocial 6 minutes ago
Exactly my cousin Mark Twain quote
RDGL
trunkmonk trunkmonk 6 minutes ago
we've only just begun..to shine...https://www.youtube.com/watch?v=uaqoQr-aCtQ
SQQQ
Volcano Volcano 7 minutes ago
Huge news just out

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Mentioned: NKGN
GlobeNewswireApril 24, 2024
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: N
NKGN
Volcano Volcano 8 minutes ago
NKGN

Another huge news out
NKGN
jack7377 jack7377 8 minutes ago
NSAV#$$: Hey Bulba, looks like this Loin Puppy is well positioned to Break the last 52 week High of $.0054 ...This is shaping up to be like '2021 , only better with 1st Qtr. Revenue estimates of $50-60 Million. PEOPLE! We are about to see an Explosion to PENNYLAND .
NSAV
Rainer Rainer 8 minutes ago
on watch for a bottom here, reminds me of a couple other tickers that fell of Nasdaq and ran again.
GGEI
RobotDroid RobotDroid 8 minutes ago
Non management staying silent is killing nwbo. Some things never change. Are they silent because they fucked up submission??? Would not suprise me. They really do not know how to communicate.
NWBO
Majic Majic 9 minutes ago
FBEC still hasn’t filed. They need to get 15c2-11 compliant ASAP -- if not, they get kicked to the expert market and goodbye stock.
The clock is ticking…

I like the potential here, but something’s wrong with this whole thing. I just can’t believe that a company would buy a tick
FBEC
BADALI BADALI 9 minutes ago
Otc needs 2023 annual , 2024 first quarter financials and then also attorney letter to remove yield sign and make this current pink.
Counsel already have all documents. Counsel just needs OTCIQ access to upload there.
IGPK
MrSmith18 MrSmith18 10 minutes ago
I guess you've never heard of SPACs, which begs me to ask, what the heck are you doing here then? Did you get on the wrong bus to cross the border? LMAO!
FORW
wisetoit wisetoit 10 minutes ago
Share Reduction Coming!!! $$$$$$
PSRU
Rainer Rainer 11 minutes ago
on watch for reversal. GLTA.
RONN
Longstrongsilver Longstrongsilver 11 minutes ago
If only sticks worked that way the answer would be to the moon, but we don’t take it anywhere. What we’re waiting on /hoping for is for the custo to close a deal with this clean shell low floater in an RM deal. Clearly these things take patience but it’s a great shell candidate so I’m sleeping easy
ZHUD
ignatiusrielly35 ignatiusrielly35 11 minutes ago
It is not a big issue for me whether they file the application next month or six months from now. I only care that it’s filed and accepted.

Go ahead and try to wait to buy, on your trade down strategy. Who cares? Personally, I will not sell any here. I’d be more likely to sell some in
AVXL

Your Recent History

Delayed Upgrade Clock